Reproducibility of the durometer and myoton devices for skin stiffness measurement in healthy subjects
Background Clinical assessment of skin stiffness is unreliable in many applications. The durometer, an industrial device to measure hardness, has previously been applied in scleroderma. The Myoton is a noninvasive handheld device for assessing soft tissue biomechanical parameters. Materials and Meth...
Saved in:
Published in | Skin research and technology Vol. 25; no. 3; pp. 289 - 293 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.05.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0909-752X 1600-0846 1600-0846 |
DOI | 10.1111/srt.12646 |
Cover
Summary: | Background
Clinical assessment of skin stiffness is unreliable in many applications. The durometer, an industrial device to measure hardness, has previously been applied in scleroderma. The Myoton is a noninvasive handheld device for assessing soft tissue biomechanical parameters.
Materials and Methods
We evaluated the reproducibility of both devices in six healthy subjects in the volar forearm, dorsal forearm, upper arm, shin, and calf bilaterally. The intraclass correlation coefficient (ICC) was used as a measure of reproducibility among three observers.
Results
The interobserver intraclass correlation coefficient (ICC) of overall stiffness for the Myoton was 0.74 [95% confidence interval (CI) 0.45‐1.00] and 0.71 [0.39‐1.00] for the durometer. Coefficient of variation (CV) for the Myoton was 6.4% [range 1.3‐12.1] and 7.6% [range 4.4‐13.8] for the durometer. Myoton and durometer values had a Pearson correlation of 0.69. The intraobserver Myoton ICC was 0.89 [0.74‐1.00] and CV 3.1% [range 1.6‐5.0]. The 95% confidence minimal detectable change by the Myoton for a single observer is 32.4 N/m, which is 7.6% of the average subject's overall stiffness.
Conclusion
The Myoton demonstrated high reproducibility, particularly in the overall stiffness parameter, and merits further investigation to assess disease progression and treatment efficacy. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ISSN: | 0909-752X 1600-0846 1600-0846 |
DOI: | 10.1111/srt.12646 |